Pharma Research Products Co., Ltd., a company that continues to grow in the
field of cosmetic products such as D+CELL 350® TRA, REJURAN® Healer signed a
binding MOU with Amorepacific Group subsidiary, Aestura Corporation (Filler
business division) following recently signed binding MOU of botulinum toxin
company, Bio C&D. It will accelerate the expansion of the aesthetic
business. The acquisition of filler business division of Aestura Corporation
will transfer technology and goodwill related to the HA filler brand ‘CLEVIEL®’
and the contract will be concluded in February 2018.